基于人工智能的乳腺癌乳腺钼靶解读的全球差异:代表性、趋势与公平性的科学计量学分析
该科学计量学分析检索PubMed与EMBASE(2024年7月),纳入264项使用筛查或诊断性乳腺钼靶训练或验证乳腺癌人工智能算法的研究,发表于2017、2018、2022和2023年。研究发现研究数量从2017年的28项增至2023年的115项(增长311%),但仅0-25%的研究报告种族/族裔,多数患者为白人,几乎所有队列来自高收入国家,作者单位也主要来自高收入地区,且第一和最后作者存在性别失衡。作者认为数据集和研究者的种族、族裔及地域多样性缺乏可能削弱AI乳腺钼靶解读的泛化性和公平性。
要点
- 研究数量从2017年的28项增至2023年的115项,增长311%。
- 仅0-25%的研究报告种族/族裔,多数患者为白人。
- 几乎所有患者队列来自高收入国家,无低收入环境研究。
核心结论
- 数据集和研究者的种族、族裔及地域多样性缺乏可能削弱基于AI的乳腺钼靶解读的泛化性和公平性。
- 通过多样化数据集收集和包容性国际合作解决这些差异对确保乳腺癌诊疗的公平改善至关重要。
研究设计与样本
- 科学计量学分析,纳入2017、2018、2022和2023年发表的264项使用筛查或诊断性乳腺钼靶训练或验证乳腺癌AI算法的研究。
- 2024年7月检索PubMed(MEDLINE)和EMBASE。
- 数据提取聚焦患者队列社会人口学(包括年龄和种族/族裔)、地理分布(按世界银行国家收入水平和区域分类)及作者概况(性别、单位和资金来源)。
主要发现
- 从5774项研究中识别出264项符合纳入标准。
- 研究数量从2017年的28项增至2023年的115项,增长311%。
- 仅0-25%的研究报告种族/族裔,多数患者被识别为白人。
- 几乎所有患者队列来自高收入国家,无低收入环境的研究。
- 作者单位主要来自高收入地区,第一和最后作者存在性别失衡。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Breast cancer (BC) is the most frequently diagnosed cancer and the leading cause of cancer death among women worldwide. Artificial intelligence (AI) shows promise for improving mammogram interpretation, especially in resource-limited settings. However, concerns remain regarding the diversity of datasets and the representation of researchers in AI model development, which may affect the models' generalizability, fairness, and equity. METHODS: We performed a scientometric analysis of studies published in 2017, 2018, 2022, and 2023 that used screening or diagnostic mammograms for BC detection to train or validate AI algorithms. PubMed (MEDLINE) and EMBASE were searched in July 2024. Data extraction focused on patient cohort sociodemographics (including age and race/ethnicity), geographic distribution (categorized by World Bank country income levels and regions), and author profiles (sex, affiliation, and funding sources). RESULTS: Of 5774 studies identified, 264 met the inclusion criteria. The number of studies increased from 28 in 2017 to 115 in 2023-a 311 % increase. Despite this growth, only 0-25 % of studies reported race/ethnicity, with most patients identified as Caucasian. Moreover, nearly all patient cohorts originated from high-income countries, with no studies from low-income settings. Author affiliations were predominantly from high-income regions, and gender imbalance was observed among first and last authors. CONCLUSION: The lack of racial, ethnic, and geographic diversity in both datasets and researcher representation could undermine the generalizability and fairness of AI-based mammogram interpretation. Addressing these disparities through diverse dataset collection and inclusive international collaborations is critical to ensuring equitable improvements in breast cancer care.
引用
- Miyawaki IA, Banerjee I, Batalini F, et al. Global disparities in artificial intelligence-based mammogram interpretation for breast cancer: A scientometric analysis of representation, trends, and equity. Eur J Cancer. 2025. PMID: 40209572. doi:10.1016/j.ejca.2025.115394
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。